Several studies have shown that IL-17A did not have statistical significance at different measurement times in patients with CRC, being shown as a cytokine that is not of potential prognosis in patients with CRC since its levels are not increased [73,76,80]. This evidence concerns the gene IL17A and colorectal carcinoma.